These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 31271463)

  • 21. Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
    Mokaya J; Burn EAO; Tamandjou CR; Goedhals D; Barnes EJ; Andersson M; Pinedo-Villanueva R; Matthews PC
    BMC Public Health; 2019 Jun; 19(1):829. PubMed ID: 31242901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testing.
    Thilakanathan C; Wark G; Maley M; Davison S; Lawler J; Lee A; Shackel N; Nguyen V; Jackson K; Glass A; Locarnini SA; Levy MT
    Liver Int; 2018 Jul; 38(7):1212-1219. PubMed ID: 29532580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B.
    Wang R; Zhu X; Zhang X; Liu H; Ji YL; Chen YH
    World J Gastroenterol; 2023 May; 29(19):3003-3012. PubMed ID: 37274802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women.
    Lu LL; Chen BX; Wang J; Wang D; Ji Y; Yi HG; Chen T; Zhang Y; Petersen E; Li Q; Qu C
    Int J Infect Dis; 2014 Nov; 28():41-4. PubMed ID: 25245000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: A meta-analysis.
    Song J; Yang F; Wang S; Tikande S; Deng Y; Tang W; Cao G
    J Viral Hepat; 2019 Mar; 26(3):397-406. PubMed ID: 30417469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV.
    Wang J; Liu J; Qi C; Yan T; Cao F; Jin L; He Y; Yang Y; Zhang S; Chen T; Zhao Y
    Antivir Ther; 2015; 20(7):681-7. PubMed ID: 26215771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up.
    Virine B; Osiowy C; Gao S; Wang T; Castillo E; Martin SR; Lee SS; Simmonds K; van Marle G; Coffin CS
    PLoS One; 2015; 10(10):e0140070. PubMed ID: 26474400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lamivudine use in pregnant HBsAg-females effectively reduces maternal viremia.
    Foaud HM; Maklad S; Gmal El Din A; Mahmoud F
    Arab J Gastroenterol; 2019 Mar; 20(1):8-13. PubMed ID: 30857834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Hepatitis B Virus in Tenofovir-Treated and Untreated Chronically Infected Mothers and Their Immunoprophylaxis Failure Infants.
    Hsu HY; Chen HL; Chiang CL; Lai MW; Mu SC; Wen WH; Cheng SW; Hu JJ; Chang KC; Lee CN; Liu CJ; Wu JF; Ni YH; Chang MH;
    Clin Infect Dis; 2023 Feb; 76(3):e783-e790. PubMed ID: 35789261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
    Duri K; Munjoma PT; Mataramvura H; Mazhandu AJ; Chandiwana P; Marere T; Gumbo FZ; Mazengera LR
    BMC Infect Dis; 2023 Oct; 23(1):736. PubMed ID: 37891471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative Hepatitis B Surface Antigen Predicts Hepatitis B Transmission in Infants Born to e Antigen-positive Mothers.
    Peng S; Wan Z; Liu T; Wang Y; Chen H; Li X; Du Y
    J Clin Gastroenterol; 2020 Jan; 54(1):76-82. PubMed ID: 30575631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China.
    Cui F; Woodring J; Chan P; Xu F
    Int J Epidemiol; 2018 Oct; 47(5):1529-1537. PubMed ID: 29757383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
    Yin YZ; Zhou J; Zhang PZ; Hou HY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring.
    Khamduang W; Gaudy-Graffin C; Ngo-Giang-Huong N; Jourdain G; Moreau A; Borkird T; Layangool P; Kamonpakorn N; Jitphiankha W; Kwanchaipanich R; Potchalongsin S; Lallemant M; Sirirungsi W; Goudeau A;
    J Clin Virol; 2013 Oct; 58(2):415-21. PubMed ID: 23916828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes.
    Chen HL; Lee CN; Chang CH; Lai MW; Tsai MC; Mu SC; Liu CJ; Shih JC; Wen WH; Hu RT; Huang CP; Hu KC; Chen CP; Lee CL; Chien RN; Chang KC; Hsu HY; Lee CC; Ni YH; Chang MH
    Liver Int; 2024 Jun; 44(6):1422-1434. PubMed ID: 38456620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission.
    Sun W; Zhao S; Ma L; Hao A; Zhao B; Zhou L; Li F; Song M
    BMC Gastroenterol; 2017 Apr; 17(1):51. PubMed ID: 28407735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection.
    Wen WH; Huang CW; Chie WC; Yeung CY; Zhao LL; Lin WT; Wu JF; Ni YH; Hsu HY; Chang MH; Lin LH; Chen HL
    Hepatology; 2016 Nov; 64(5):1451-1461. PubMed ID: 27044007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.
    Zhang L; Gui XE; Wang B; Fan JY; Cao Q; Mullane K; Liang XL
    BMC Infect Dis; 2016 Aug; 16(1):408. PubMed ID: 27515176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus.
    Han L; Zhang HW; Xie JX; Zhang Q; Wang HY; Cao GW
    World J Gastroenterol; 2011 Oct; 17(38):4321-33. PubMed ID: 22090789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tenofovir rescue therapy in pregnant females with chronic hepatitis B.
    Hu YH; Liu M; Yi W; Cao YJ; Cai HD
    World J Gastroenterol; 2015 Feb; 21(8):2504-9. PubMed ID: 25741161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.